Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of KNG1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of KNG1 mRNA | affects expression | 21346803
|
C031285 |
3-xylene |
3-xylene results in increased expression of KNG1 mRNA | increases expression | 12815608
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of KNG1 protein | affects expression | 20106945
|
D017962 |
alpha-Linolenic Acid |
alpha-Linolenic Acid inhibits the reaction [GW 4064 results in increased expression of KNG1 mRNA] | decreases reaction|increases expression | 15307955
|
D016718 |
Arachidonic Acid |
Arachidonic Acid inhibits the reaction [GW 4064 results in increased expression of KNG1 mRNA] | decreases reaction|increases expression | 15307955
|
C095105 |
bexarotene |
bexarotene results in increased expression of KNG1 mRNA | increases expression | 17849452
|
C095105 |
bexarotene |
bexarotene results in decreased expression of KNG1 mRNA | decreases expression | 16648578
|
C082229 |
bradykinin, Lys-Leu(8)-desArg(9)- |
bradykinin, Lys-Leu(8)-desArg(9)- affects the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] | affects binding|affects reaction|increases abundance|increases activity | 17347322
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in increased expression of KNG1 mRNA | increases expression | 19925653
|
D002118 |
Calcium |
BDKRB2 protein affects the reaction [KNG1 protein affects the abundance of Calcium] | affects abundance|affects reaction | 18054572
|
D002118 |
Calcium |
KNG1 protein affects the abundance of Calcium | affects abundance | 18054572
|
D002118 |
Calcium |
KNG1 protein results in increased abundance of Calcium | increases abundance | 10535458
|
D002118 |
Calcium |
KNG1 protein results in increased transport of Calcium | increases transport | 11812640
|
D002118 |
Calcium |
[KNG1 protein alternative form co-treated with Calcium] results in increased secretion of CALCA protein | affects cotreatment|increases secretion | 17666428
|
D002211 |
Capsaicin |
KNG1 protein alternative form affects the reaction [P2RY2 protein affects the susceptibility to Capsaicin] | affects reaction|affects response to substance | 18343036
|
D002211 |
Capsaicin |
Capsaicin inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] | affects binding|decreases reaction|increases abundance|increases activity | 17347322
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of KNG1 mRNA | increases expression | 16644059
|
D002251 |
Carbon Tetrachloride |
KNG1 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] | decreases reaction|increases expression | 18054572
|
D002251 |
Carbon Tetrachloride |
KNG1 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A1 protein] | decreases reaction|increases expression | 18054572
|
D002251 |
Carbon Tetrachloride |
KNG1 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein] | decreases reaction|increases expression | 18054572
|
C511403 |
CGS 35601 |
CGS 35601 affects the expression of KNG1 protein | affects expression | 16364833
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of KNG1 mRNA | decreases expression | 20106945
|
D004281 |
Docosahexaenoic Acids |
Docosahexaenoic Acids inhibits the reaction [GW 4064 results in increased expression of KNG1 mRNA] | decreases reaction|increases expression | 15307955
|
D004958 |
Estradiol |
Estradiol results in decreased expression of KNG1 mRNA | decreases expression | 20106945
|
D005472 |
Fluorouracil |
[Fluorouracil co-treated with irinotecan] results in decreased expression of KNG1 mRNA | affects cotreatment|decreases expression | 16391804
|
C105311 |
FR 173657 |
FR 173657 inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] | affects binding|decreases reaction|increases activity | 11104833
|
C105311 |
FR 173657 |
FR 173657 inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] | affects binding|decreases reaction|increases activity | 15140628
|
C105311 |
FR 173657 |
FR 173657 inhibits the reaction [KNG1 protein alternative form results in increased activity of MAPK3 protein] | decreases reaction|increases activity | 11139431
|
C412815 |
GW 4064 |
alpha-Linolenic Acid inhibits the reaction [GW 4064 results in increased expression of KNG1 mRNA] | decreases reaction|increases expression | 15307955
|
C412815 |
GW 4064 |
Arachidonic Acid inhibits the reaction [GW 4064 results in increased expression of KNG1 mRNA] | decreases reaction|increases expression | 15307955
|
C412815 |
GW 4064 |
Docosahexaenoic Acids inhibits the reaction [GW 4064 results in increased expression of KNG1 mRNA] | decreases reaction|increases expression | 15307955
|
C412815 |
GW 4064 |
GW 4064 results in increased expression of KNG1 mRNA | increases expression | 15307955
|
D019812 |
Heparan Sulfate Proteoglycans |
KNG1 protein results in increased abundance of Heparan Sulfate Proteoglycans | increases abundance | 12639806
|
C065679 |
icatibant |
icatibant inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] | affects binding|decreases reaction|increases activity | 11104833
|
C065679 |
icatibant |
icatibant inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] | affects binding|decreases reaction|increases activity | 15140628
|
C065679 |
icatibant |
icatibant inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] | affects binding|decreases reaction|increases abundance|increases activity | 17347322
|
D007295 |
Inositol Phosphates |
bradykinin, Lys-Leu(8)-desArg(9)- affects the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] | affects binding|affects reaction|increases abundance|increases activity | 17347322
|
D007295 |
Inositol Phosphates |
Capsaicin inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] | affects binding|decreases reaction|increases abundance|increases activity | 17347322
|
D007295 |
Inositol Phosphates |
icatibant inhibits the reaction [[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates] | affects binding|decreases reaction|increases abundance|increases activity | 17347322
|
D007295 |
Inositol Phosphates |
[KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] which results in increased abundance of Inositol Phosphates | affects binding|increases abundance|increases activity | 17347322
|
C051890 |
irinotecan |
[Fluorouracil co-treated with irinotecan] results in decreased expression of KNG1 mRNA | affects cotreatment|decreases expression | 16391804
|
C403051 |
LF 16-0687 |
LF 16-0687 inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] | affects binding|decreases reaction|increases activity | 15140628
|
C119318 |
MEN 11270 |
MEN 11270 inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] | affects binding|decreases reaction|increases activity | 11104833
|
C119318 |
MEN 11270 |
MEN 11270 inhibits the reaction [KNG1 protein alternative form binds to and results in increased activity of BDKRB2 protein] | affects binding|decreases reaction|increases activity | 15140628
|
D008748 |
Methylcholanthrene |
AHR protein promotes the reaction [Methylcholanthrene results in decreased expression of KNG1 mRNA] | decreases expression|increases reaction | 11549291
|
D008748 |
Methylcholanthrene |
AHR protein promotes the reaction [Methylcholanthrene results in decreased expression of KNG1 protein] | decreases expression|increases reaction | 11549291
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of KNG1 mRNA | decreases expression | 11549291
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of KNG1 protein | decreases expression | 11549291
|
D009569 |
Nitric Oxide |
KNG1 protein results in increased abundance of Nitric Oxide | increases abundance | 10535458
|
D009569 |
Nitric Oxide |
ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 12672649
|
D009569 |
Nitric Oxide |
KNG1 protein results in increased abundance of Nitric Oxide | increases abundance | 12672649
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of KNG1 mRNA | affects expression | 17450228
|
D012967 |
Sodium Dodecyl Sulfate |
Sodium Dodecyl Sulfate results in increased expression of KNG1 mRNA | increases expression | 12815608
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of KNG1 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of KNG1 mRNA | increases expression | 15644576
|
C017963 |
vinyl carbamate |
vinyl carbamate results in increased expression of KNG1 mRNA | increases expression | 17849452
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
7.71 | 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.71 | 11752688 14514962 15322242 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
4.28 | 18460982 |
MESH:D055371 |
Acute Lung Injury |
|
3-xylene |
5.05 | 15204773 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.87 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
6.87 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
vinyl carbamate |
6.87 | 17363558 16247444 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
3.33 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.70 | 16835633 |
MESH:D018248 |
Adenoma, Liver Cell |
|
vinyl carbamate |
9.70 | 12371669 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.40 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.60 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
4.50 | 17569567 |
MESH:D000544 |
Alzheimer Disease |
|
Nitric Oxide |
3.25 | 17556102 |
MESH:D000707 |
Anaphylaxis |
marker/mechanism |
|
| 7623993 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.83 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.83 | 11748828 |
MESH:D001249 |
Asthma |
|
FR 173657 |
5.01 | 12706475 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.28 | 11922910 |
MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
2.88 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Docosahexaenoic Acids |
2.88 | 18582451 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.78 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.49 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.58 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
4.76 | 18207255 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
4.68 | 19211983 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
2.82 | 16818667 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.82 | 12948864 17261762 17289903 18497071 16675129 14630087 19861407 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.82 | 15136595 16595493 19217205 18608205 16110121 18357371 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.82 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Nitric Oxide |
2.82 | 15631943 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.82 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.17 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.49 | 16011737 15721981 16192424 16227642 10355542 15700767 16124888 15673190 3786805 18705752 16050911 16097048 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.37 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
12.65 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
12.65 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
12.65 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
16.01 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
16.01 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
16.01 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
16.01 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
16.01 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
16.01 | 17088986 17045692 18930000 17971768 16799960 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
16.01 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
vinyl carbamate |
16.01 | 12371669 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
5.94 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
vinyl carbamate |
5.94 | 16247446 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.88 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.46 | 18986760 16757204 16280240 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.46 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.21 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
18.96 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
18.96 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
18.96 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
18.96 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
18.96 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.92 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.64 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Nitric Oxide |
7.64 | 16919318 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.98 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.77 | 17725105 16340194 15001691 18772588 16510598 17172411 17287894 17016597 17018589 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
3.77 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.65 | 17094418 17401013 16391804 16282729 15289873 17695437 17255274 17454858 18949393 18383874 18288408 18509181 14970324 16303861 17594712 16524972 17016601 20501625 18448328 15148649 16331619 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.65 | 17159606 16391804 15273666 18259882 17454858 16303861 18509181 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 17141729 14669216 |
MESH:D003371 |
Cough |
|
Capsaicin |
4.88 | 10350223 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 15322242 10048152 20055451 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.93 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.93 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Docosahexaenoic Acids |
4.42 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.50 | 16733453 |
MESH:D015140 |
Dementia, Vascular |
|
Nitric Oxide |
5.66 | 17556102 |
MESH:D003872 |
Dermatitis |
|
3-xylene |
5.60 | 15902427 12717741 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.60 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.17 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.19 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.19 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.19 | 3786805 17522070 15998439 15968718 11566570 4309450 7120509 16177239 15027814 2869522 6623471 21278145 10092053 16227642 7440962 19085960 3732212 10915739 19336974 9327722 7179309 6884620 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.19 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.55 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
4.41 | 11535926 10671773 |
MESH:D004487 |
Edema |
|
Arachidonic Acid |
6.25 | 7990266 16716910 9831321 11698051 9599246 15177302 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.25 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.60 | 16714409 15322242 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.79 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.77 | 10568697 9294722 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
5.41 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.38 | 16785472 16337965 16481741 15173087 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
6.84 | 15959796 19224547 12795759 17595544 12631006 61145 16045604 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
6.84 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.17 | 11858732 |
MESH:D005334 |
Fever |
|
Arachidonic Acid |
4.40 | 11852909 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.64 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
13.04 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.04 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.04 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.38 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.92 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
3.93 | 18405923 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.75 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.29 | 10696789 |
MESH:D006261 |
Headache |
|
Nitric Oxide |
4.88 | 11284996 11554966 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.19 | 18337622 15162350 15102660 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
5.41 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.18 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.13 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.07 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.32 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.61 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.73 | 15709030 |
OMIM:228960 |
HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY |
marker/mechanism |
|
| |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.91 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.45 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.75 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
marker/mechanism |
|
| 16793879 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
8.35 | 17043245 17434803 |
MESH:D006930 |
Hyperalgesia |
|
icatibant |
8.35 | 12727271 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.24 | 16899240 |
MESH:D006940 |
Hyperemia |
|
Nitric Oxide |
5.32 | 11156591 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
4.25 | 17604070 |
MESH:D006973 |
Hypertension |
|
CGS 35601 |
8.18 | 16364833 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.18 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.18 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.80 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Nitric Oxide |
4.21 | 15838368 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.80 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
7.68 | 15177302 9831321 17371808 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
7.68 | 16956363 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.68 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.78 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Nitric Oxide |
4.64 | 10210152 11713966 11574821 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.14 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.07 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.07 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.07 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
20.81 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
20.81 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
20.81 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
20.81 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
20.81 | 16985049 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.75 | 16316344 |
MESH:D007896 |
Leishmaniasis |
|
Nitric Oxide |
4.41 | 17218153 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Docosahexaenoic Acids |
4.74 | 17077332 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.65 | 16221502 11903743 17157831 11408273 21278145 16943688 17174718 16239168 17334410 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
therapeutic |
|
| 18054572 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.22 | 12741479 18412020 16011737 12632514 18705752 12546737 15057751 12649538 15893842 17714472 20821823 15730626 18317297 16015684 18263696 15931870 13678700 18472094 17944888 12445418 18429990 18376398 11481614 18251166 18187930 15338365 12958196 15925388 15650968 16136751 17631135 18210741 17900296 18395914 18418968 18054572 18395095 14620537 17766677 12898905 14724832 12389079 18166357 17557913 12609069 17698563 17976157 16638106 16027843 17805973 12586293 12445421 18156304 15876570 12667390 17481882 15123356 15370692 16116963 14512876 15052691 15673190 18420326 17761835 15959796 15818738 17565644 17640975 16097048 17869086 14716833 16248980 15362042 17922224 17721639 17708605 18339082 18006644 16192424 14716496 15996030 12666154 18481824 18472332 18205269 18277467 12632512 14748882 17525996 17823541 10355542 18279442 16033810 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.22 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.22 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
6.39 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.39 | 15830285 16964402 17285989 16246199 15720792 |
MESH:D008107 |
Liver Diseases |
|
Docosahexaenoic Acids |
6.39 | 17056761 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.87 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.43 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
20.12 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
20.12 | 9163691 2125692 15890375 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
20.12 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
20.12 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
20.12 | 15113037 16603448 18383874 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
20.12 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.12 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
16.70 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
16.70 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
16.70 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
16.70 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
16.70 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.98 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Nitric Oxide |
4.43 | 11395602 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
12.29 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
12.29 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
12.29 | 11696405 16337739 19925653 11246140 19359593 15390079 18597497 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
12.29 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
12.29 | 15390079 21163286 16337739 17909032 20970405 10545420 9230183 6695378 1399818 20512841 7750092 11893704 16271038 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.29 | 17077188 17306315 15276417 16712894 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.29 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
vinyl carbamate |
12.29 | 15172992 11195469 17361011 16247444 15824018 17363558 11134547 14755239 17163412 12438228 16885199 12765245 12117777 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.50 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Nitric Oxide |
4.07 | 16166326 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.86 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
9.10 | 19196723 15591091 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
9.10 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.10 | 16891317 11807958 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.18 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
1.99 | 19082730 16487513 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.49 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Nitric Oxide |
4.07 | 11701602 |
MESH:D020326 |
Migraine without Aura |
|
Nitric Oxide |
4.83 | 11304026 14659530 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.41 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.71 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
3.95 | 17505005 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.79 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.06 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.36 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.36 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.05 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
4.70 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.70 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.38 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.48 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.44 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.14 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.04 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.53 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.53 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
2.95 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.33 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.43 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
4.82 | 17961222 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
3-xylene |
7.95 | 7820390 8907413 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
7.95 | 16436463 |
MESH:D009765 |
Obesity |
|
Capsaicin |
3.32 | 19056576 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.04 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.04 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.60 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.52 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.52 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Capsaicin |
3.79 | 17043245 19081190 17084039 16996476 18987195 17434803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.56 | 19003803 16929163 16500647 15113037 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.95 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
4.87 | 11893704 |
MESH:D011015 |
Pneumonia, Aspiration |
|
Nitric Oxide |
5.04 | 18573544 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.28 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.98 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.90 | 11399792 11896295 11222880 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.62 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.67 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.67 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.67 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.12 | 16882103 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.76 | 18722050 16160472 15538739 18286688 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
3.82 | 18460982 19211983 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.56 | 18990726 |
MESH:D012555 |
Schistosomiasis mansoni |
|
Nitric Oxide |
5.16 | 9673227 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.89 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
8.89 | 18551238 |
MESH:D012640 |
Seizures |
|
3-xylene |
8.89 | 8907413 6431079 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.13 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.13 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.57 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Docosahexaenoic Acids |
3.47 | 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.47 | 18396642 17498489 17522103 16951190 16424979 19084572 18567086 19015929 15786421 17172411 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.47 | 15723263 |
MESH:D013276 |
Stomach Ulcer |
|
Nitric Oxide |
3.94 | 15138204 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
5.42 | 17997062 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.60 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.39 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.73 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
7.61 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
7.61 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.61 | 16452187 16712894 11723127 17306315 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.00 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.00 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.64 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.64 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.68 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.13 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.29 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.95 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.14 | 17120751 |